Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Arthritis Research & Therapy
|
November 28, 2008
Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort
Isidoro González-Alvaro, Miguel Angel Descalzo, Loreto Carmona, et al.
Reumatologia Clinica
|
July 29, 2011
Pattern of use and safety of non-steroidal anti-inflammatory drugs in rheumatoid arthritis patients. A prospective analysis from clinical practice
Iván Ferraz-Amaro, Sergio Machín, Loreto Carmona, et al.
The Journal of Rheumatology
|
January 6, 2004
Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis
Alejandro Balsa, Loreto Carmona, Isidoro González-Alvaro, et al.
Medicina Clinica
|
June 7, 2002
[Variations in the drug treatment of rheumatoid arthritis in Spain]
Isidoro González-Alvaro, César Hernández-García, Virginia Villaverde García, et al.
Seminars in Arthritis and Rheumatism
|
November 6, 2007
Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population
Lydia Abásolo, Enrique Júdez, Miguel Angel Descalzo, et al.
Trials
|
September 10, 2020
Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial
Rosario Garcia-Vicuña, Francisco Abad-Santos, Isidoro González-Alvaro, et al.
Diagnostics (Basel, Switzerland)
|
July 27, 2022
Anti-Citrullinated Protein Antibody Titers Are Independently Modulated by Both Disease Activity and Conventional or Biologic Anti-Rheumatic Drugs
Miren Uriarte Ecenarro, Daniel Useros, Aranzazu Alfranca, et al.
The Journal of Rheumatology
|
May 18, 2010
Estimated cutoff points for the 28-joint disease activity score based on C-reactive protein in a longitudinal register of early arthritis
Isabel Castrejón, Ana M Ortiz, Esther Toledano, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
June 19, 2007
Reproducibility of metacarpophalangeal bone mass measurements obtained by dual-energy X-ray absorptiometry in healthy volunteers and patients with early arthritis
Santos Castañeda, Isidoro González-Alvaro, Francisco Rodríguez-Salvanés, et al.
Arthritis Research & Therapy
|
March 25, 2010
A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass
Monica Ibañez, Ana M Ortiz, Isabel Castrejón, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Arthritis Research & Therapy
|
November 28, 2008
Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort
Isidoro González-Alvaro, Miguel Angel Descalzo, Loreto Carmona, et al.
Reumatologia Clinica
|
July 29, 2011
Pattern of use and safety of non-steroidal anti-inflammatory drugs in rheumatoid arthritis patients. A prospective analysis from clinical practice
Iván Ferraz-Amaro, Sergio Machín, Loreto Carmona, et al.
The Journal of Rheumatology
|
January 6, 2004
Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis
Alejandro Balsa, Loreto Carmona, Isidoro González-Alvaro, et al.
Medicina Clinica
|
June 7, 2002
[Variations in the drug treatment of rheumatoid arthritis in Spain]
Isidoro González-Alvaro, César Hernández-García, Virginia Villaverde García, et al.
Seminars in Arthritis and Rheumatism
|
November 6, 2007
Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population
Lydia Abásolo, Enrique Júdez, Miguel Angel Descalzo, et al.
Trials
|
September 10, 2020
Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial
Rosario Garcia-Vicuña, Francisco Abad-Santos, Isidoro González-Alvaro, et al.
Diagnostics (Basel, Switzerland)
|
July 27, 2022
Anti-Citrullinated Protein Antibody Titers Are Independently Modulated by Both Disease Activity and Conventional or Biologic Anti-Rheumatic Drugs
Miren Uriarte Ecenarro, Daniel Useros, Aranzazu Alfranca, et al.
The Journal of Rheumatology
|
May 18, 2010
Estimated cutoff points for the 28-joint disease activity score based on C-reactive protein in a longitudinal register of early arthritis
Isabel Castrejón, Ana M Ortiz, Esther Toledano, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
June 19, 2007
Reproducibility of metacarpophalangeal bone mass measurements obtained by dual-energy X-ray absorptiometry in healthy volunteers and patients with early arthritis
Santos Castañeda, Isidoro González-Alvaro, Francisco Rodríguez-Salvanés, et al.
Arthritis Research & Therapy
|
March 25, 2010
A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass
Monica Ibañez, Ana M Ortiz, Isabel Castrejón, et al.
Page
of 4